Overall  	Overall  	 JJ	O
survival  	survival  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
re-excision  	re-excision  	 JJ	B-NP
following  	following  	 JJ	O
breast  	breast  	 NN	O
conserving  	conserving  	 NN	O
surgery  	surgery  	 NN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
those  	those  	 DT	O
without  	without  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
population-based  	population-based  	 JJ	B-NP
cohort  	cohort  	 NN	I-NP
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	O
of  	of  	 IN	O
invasive  	invasive  	 JJ	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
primary  	primary  	 JJ	B-NP
breast  	breast  	 NN	I-NP
conserving  	conserving  	 NN	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
BCS 	BCS 	 NNP	B-NP
)  	)  	 -RRB-	O
followed  	followed  	 VBD	O
by  	by  	 IN	O
re-excision  	re-excision  	 JJ	B-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
those  	those  	 DT	O
with  	with  	 IN	O
primary  	primary  	 JJ	B-NP
BCS  	BCS  	 NNP	I-NP
only 	only 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
Dutch  	Dutch  	 JJ	O
re-excision  	re-excision  	 JJ	B-NP
indications  	indications  	 NNS	I-NP
are  	are  	 VBP	O
less  	less  	 RBR	O
stringent  	stringent  	 JJ	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
other  	other  	 JJ	O
European  	European  	 JJ	O
and  	and  	 CC	O
Northern  	Northern  	 NNP	O
American  	American  	 NNP	O
countries  	countries  	 NNS	O
( 	( 	 -LRB-	O
Society  	Society  	 NNP	O
of  	of  	 IN	O
Surgical  	Surgical  	 NNP	B-NP
Oncology-American  	Oncology-American  	 NNP	I-NP
Society  	Society  	 NNP	I-NP
for  	for  	 IN	I-NP
Radiation  	Radiation  	 NNP	I-NP
Oncology  	Oncology  	 NNP	I-NP
( 	( 	 -LRB-	O
SSO 	SSO 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ASTRO 	ASTRO 	 NNP	I-NP
)  	)  	 -RRB-	O
guideline 	guideline 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Retrospective  	Retrospective  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
in  	in  	 IN	O
women  	women  	 NNS	O
< 	< 	 SYM	O
75years  	75years  	 VBP	O
with  	with  	 IN	O
breast  	breast  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
stage  	stage  	 NN	I-NP
pT1-T3  	pT1-T3  	 VBZ	I-NP
treated  	treated  	 VBN	O
by  	by  	 IN	O
BCS  	BCS  	 NNP	B-NP
and  	and  	 CC	O
radiotherapy  	radiotherapy  	 NN	O
between  	between  	 IN	O
1999  	1999  	 CD	O
and  	and  	 CC	O
2012  	2012  	 CD	O
from  	from  	 IN	O
a  	a  	 DT	O
population-based  	population-based  	 JJ	B-NP
database 	database 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
national  	national  	 JJ	O
guideline  	guideline  	 NN	O
recommends  	recommends  	 VBZ	O
to  	to  	 TO	O
reserve  	reserve  	 VB	O
re-excision  	re-excision  	 JJ	B-NP
for  	for  	 IN	I-NP
invasive  	invasive  	 JJ	I-NP
tumours  	tumours  	 JJ	I-NP
showing  	showing  	 NN	O
' 	' 	 POS	O
more  	more  	 JJR	O
than  	than  	 IN	O
focally  	focally  	 JJ	B-NP
positive 	positive 	 NN	I-NP
'  	'  	 POS	O
margin  	margin  	 NN	O
since  	since  	 IN	O
2002 	2002 	 CD	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
' 	' 	 POS	O
primary  	primary  	 JJ	B-NP
BCS  	BCS  	 NNP	I-NP
only 	only 	 RB	O
' 	' 	 POS	O
,  	,  	 ,	O
' 	' 	 ''	O
re-excision  	re-excision  	 JJ	B-NP
by  	by  	 IN	O
BCS 	BCS 	 NNP	B-NP
' 	' 	 POS	O
,  	,  	 ,	O
and  	and  	 NNP	O
' 	' 	 POS	O
re-excision  	re-excision  	 JJ	B-NP
by  	by  	 IN	O
mastectomy 	mastectomy 	 NN	B-NP
' 	' 	 POS	O
.  	.  	 .	O
Multivariable  	Multivariable  	 NNP	B-NP
Cox  	Cox  	 NNP	I-NP
regression  	regression  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
adjusted  	adjusted  	 VBN	O
for  	for  	 IN	O
patient  	patient  	 NN	O
and  	and  	 CC	O
systemic  	systemic  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
characteristics 	characteristics 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
11,695  	11,695  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
included  	included  	 VBN	O
of  	of  	 IN	O
which  	which  	 WDT	O
2156  	2156  	 CD	O
( 	( 	 -LRB-	O
18.4 	18.4 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
underwent  	underwent  	 VBD	O
re-excision 	re-excision 	 JJ	B-NP
.  	.  	 .	O
Median  	Median  	 JJ	B-NP
time  	time  	 NN	I-NP
of  	of  	 IN	O
follow-up  	follow-up  	 NNP	O
was  	was  	 VBD	O
61months  	61months  	 CD	O
( 	( 	 -LRB-	O
interquartile  	interquartile  	 JJ	B-NP
range  	range  	 NN	I-NP
( 	( 	 -LRB-	O
IQR 	IQR 	 NNP	B-NP
)  	)  	 -RRB-	O
26-101 	26-101 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
5-year  	5-year  	 JJ	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	B-NP
rates  	rates  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
' 	' 	 POS	O
primary  	primary  	 JJ	B-NP
BCS  	BCS  	 NNP	I-NP
only 	only 	 RB	O
' 	' 	 POS	O
,  	,  	 ,	O
' 	' 	 ''	O
re-excision  	re-excision  	 JJ	B-NP
by  	by  	 IN	O
BCS 	BCS 	 NNP	B-NP
'  	'  	 POS	O
and  	and  	 NN	O
' 	' 	 POS	O
re-excision  	re-excision  	 JJ	B-NP
by  	by  	 IN	O
mastectomy 	mastectomy 	 NN	B-NP
'  	'  	 POS	O
group  	group  	 NN	O
were  	were  	 VBD	O
92 	92 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
95 	95 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
91 	91 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
10-year  	10-year  	 JJ	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	B-NP
rates  	rates  	 NNS	I-NP
were  	were  	 VBD	O
81 	81 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
82 	82 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
79 	79 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively  	respectively  	 RB	O
( 	( 	 -LRB-	O
P=0.20 	P=0.20 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
After  	After  	 IN	O
multivariable  	multivariable  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
no  	no  	 DT	O
significant  	significant  	 JJ	O
association  	association  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
between  	between  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
and  	and  	 CC	O
type  	type  	 NN	O
of  	of  	 IN	O
re-excision  	re-excision  	 JJ	B-NP
and  	and  	 CC	O
overall  	overall  	 JJ	O
survival 	survival 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	O
of  	of  	 IN	O
breast  	breast  	 JJ	O
cancer  	cancer  	 NN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
re-excision  	re-excision  	 NN	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
differ  	differ  	 VB	O
from  	from  	 IN	O
the  	the  	 DT	O
survival  	survival  	 NN	O
of  	of  	 IN	O
women  	women  	 NNS	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
primary  	primary  	 JJ	B-NP
BCS  	BCS  	 NNP	I-NP
only 	only 	 RB	O
.  	.  	 .	O
Advising  	Advising  	 VBG	B-NP
re-excision  	re-excision  	 JJ	I-NP
only  	only  	 JJ	O
for  	for  	 IN	O
those  	those  	 DT	O
tumours  	tumours  	 JJ	O
showing  	showing  	 NN	O
' 	' 	 POS	O
more  	more  	 JJR	O
than  	than  	 IN	O
focally  	focally  	 JJ	B-NP
positive 	positive 	 NN	I-NP
'  	'  	 POS	O
resection  	resection  	 JJ	B-NP
margin  	margin  	 NN	I-NP
appears  	appears  	 VBZ	O
safe 	safe 	 JJ	O
,  	,  	 ,	O
supposing  	supposing  	 VBG	O
the  	the  	 DT	O
long-term  	long-term  	 JJ	O
safety  	safety  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
recent  	recent  	 JJ	O
SSO 	SSO 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ASTRO  	ASTRO  	 NNP	I-NP
guideline  	guideline  	 NN	I-NP
that  	that  	 IN	O
more  	more  	 RBR	O
cautiously  	cautiously  	 RB	O
recommended  	recommended  	 VBN	B-NP
re-excision  	re-excision  	 JJ	I-NP
for  	for  	 IN	O
tumours  	tumours  	 JJ	O
showing  	showing  	 NN	O
' 	' 	 POS	O
ink  	ink  	 NN	O
on  	on  	 IN	O
tumour 	tumour 	 NN	O
' 	' 	 POS	O
.  	.  	 .	O
